(ü 622) |
|
|
|
|
[] 9 ġ ӻ, 2Ⱓ
캴 ̿ ġ CSL (CSL Behring) ӻ 3 Ϳ 캴B ȯڸ ġ н(Hemgenix, Etranacogene dezaparvovec)
2023-01-02
|
|
|
|
|
[] ȸ, 2022 б ǥ
̱ б ̿Ʈ(BioMatrix Specialty Pharmacy) б α 6 ǥ, ڴ 1,000 ް ȴ.̱쿬(HFA) Ǵ
2022-12-26
|
|
|
|
|
[] ̱ 캴 ٶ ѱ '쿵'
ֱٿ, ѱ TV '̻ ȣ 쿵' ƺ ִ. ȣ ׳డ λ, ΰ 迡 ϴ, غϱ ּ ϴ ̾߱⸦ ִ.
2022-12-14
|
|
|
|
|
[] 캴 ġ 'Ӱɼ' Ӹ ´
2022 10 27 28, 쿬(WFH) 2 åмȸ(GPAS, Global Policy and Access Summit) ߴ. ¶ ȭȸǷ ̹ ϴ ҵ 迡 ȯ ġḦ
2022-12-08
|
|
|
|
|
[] WFH 캴 ȯڸ ?
쿬(WFH) 鿡 ġḦ ϱ ذڵ ϰ ִ. ̴ α Ǹ, ϳ ߵ ȯ Ŀ´Ƽ ε ġ Ȱ
2022-12-07
|
|
|
|
|
[] 캴 ġ 'A,B Ÿ '
(Centessa) ø ǥ 캴A B ü ¿ ִ ġ ǽ(SerpicPC) ֿ ӻ迡 캴 ȯڿ Ǵ PRESent-5 ̴.ȸ
2022-12-02
|
|
|
|
|
[] ȭ ġ ߰
ֱ , ȯ ο ġ () 캴 B 콺 ȿ ־. ⼺ ġḦ Ƶ뿬̷(Adeno-associated viru
2022-11-29
|
|
|
|
|
[] " ȭ 캴 ġ ?"
쿬(WFH) 캴 ȯ ġ ǻ ȭ ο WFH ' ǻ '(Shared Decision Making Tool) ϰ ִٰ ǥϰ Ǿ ڶٴ .캴 ȯ(PW
2022-11-21
|
|
|
|
|
[] 캴A Ҿ ȯ ü
̱ ǿ(The National Institutes of Health, NIH) A ȯ ȭ ü Ǵ õ ҿ ⺻ Ŀ ϰ ִ.NIH , ,
2022-11-20
|
|
|
|
|
[] 캴A ġ, FDA
̱ǰǾ౹(FDA) ̿ 캴A ȯڸ ġ 'Ÿ(߷ ϻĺ, valoctocogene roxaparvovec)' û Ƶ鿴. FDA Ÿ ̱
2022-11-03
|
|
|
|
|
[] FDA, 캴A ü TI-168 ӻ
̱ ǰǾ౹(FDA) ȸ ̹ 캴A ȯ ü ϵ T ġ TI-168 ӻ 1/2a ϵ 㰡ߴ. ̹ ӻ ġ (ġ) ü õ() 캴A
2022-11-02
|
|
|
|
|
[] ڷγ19 , õ 캴A ־
Ű , ڷγ19 鿪 ڱء ۿϹǷ ǻ ̷ 迡 氢 ִ. ڷγ19 鿪 ü踦 ڱϱ 캴A ڰ鿪ȯ ο
2022-10-31
|
|
|
|
|
[] ̿, FDA Ÿ û
Ÿ 캴A ġϴ ̱ ġ δ.̿ 캴A ȯڸ ġ Ÿ(߷ ϻĺ, valoctocogene roxaparvovec) û
2022-10-28
|
|
|
|
|
[] "캴A ġ, -ȿ "
캴A 1ȸ ġ Ÿ(Roctavian, valoctocogene roxaparvovec) εȴٸ ٸ ġ, Ư (Hemlibra) Ͽ ȯڴ ȿ ̶
2022-10-27
|
|
|
|
|
|
|
[] ̿ "Ÿ ġ , "
Ÿ(Roctavian, valoctocogene roxaparvovec) 캴A ġ ӻ迡 ۷ι ʸ ӻ 䱸 ˷.ֱ 캴A
2022-10-23
|
|
|
|
|
[] 쿬, MSKȸ Ȯ '2023 ġ '
쿬(WFH) ij Ʈÿ ȸ ̾ 2023 ٰ(MSK) ȸ Ȯ ȯ MSK ֽ ִ ' ġ '(Comprehensive Ca
2022-10-19
|
|
|
|
|
[] WFH ° '۷ι å ' ڴ?
WFH 10 27ϰ 28Ͽ 2ȸ ۷ι å (GAPS=Global Policy and Access Summit) ̶ . WFH GAPS ȭϴ 浥 迡 ȯ ġḦ ϰ Ű
2022-10-18
|
|
|
|
|
|
|